Quest Diagnostics, Inc.

  • Market Cap: Mid Cap
  • Industry: Miscellaneous
  • ISIN: US74834L1008
USD
184.18
1.57 (0.86%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Quest Diagnostics, Inc. stock-summary
stock-summary
Quest Diagnostics, Inc.
Miscellaneous
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.
Company Coordinates stock-summary
Company Details
500 Plaza Dr , SECAUCUS NJ : 07094-3619
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 158 Schemes (42.44%)

Foreign Institutions

Held by 344 Foreign Institutions (21.73%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Stephen Rusckowski
Chairman of the Board, President, Chief Executive Officer
Dr. Daniel Stanzione
Lead Independent Director
Ms. Vicky Gregg
Independent Director
Mr. Wright Lassiter
Independent Director
Mr. Timothy Main
Independent Director
Ms. Denise Morrison
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
2,761 Million
(Quarterly Results - Jun 2025)
Net Profit:
295 Million
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 29,720 Million (Mid Cap)

stock-summary
P/E

28.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

87.16%

stock-summary
Debt Equity

0.76

stock-summary
Return on Equity

14.78%

stock-summary
Price to Book

4.11